Age-related loss of skeletal muscle mass and function, sarcopenia, is associated with
physical frailty and increased risk of morbidity (chronic diseases), in addition to all-cause …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Sarcopenia is a progressive, generalized skeletal muscle disorder characterized by
reduction of muscle mass and strength. It is associated with increased adverse outcomes …

Introduction A precise quantitative measurement of skeletal muscle mass is fundamental for
diagnosing sarcopenia in older individuals. The current techniques of assessment, including …

OBJECTIVE. The purpose of this article is to review the nomenclature, clinical impact, and
diagnostic techniques characterizing sarcopenia. CONCLUSION. Sarcopenia—defined as …

Due to improved health care, diet and infrastructure in developed countries, since 1840 life
expectancy has increased by approximately 2 years per decade. Accordingly, by 2050, a …

The global pandemic of sarcopenia, skeletal muscle loss and weakness, which prevails in
up to 50% of older adults is increasing worldwide due to the expansion of aging populations …

Sarcopenia refers to the gradual loss of skeletal muscle mass and function along with aging
and is a social burden due to growing healthcare cost associated with a super-aging society …

Skeletal muscles comprise a substantial portion of whole body mass and are integral for
locomotion and metabolic health. Increasing age is associated with declines in both muscle …

Healthy individuals maintain remarkably constant skeletal muscle mass across much of
adult life, suggesting the existence of robust homeostatic mechanisms. Muscle exists in …